Overview:

Dr. Daniel DeBrouse is a scientist specializing in molecular microbiology and biotechnology. He is known for his work in biomimicry, drug delivery technologies, and innovative biodegradable materials.

He founded MicroTech in 1998, a private lab focusing on rapid microbiological and chemical analyses of food, including pioneering RNA probe–based assays to detect pathogens like Listeria in just 18 hours.

Around 2008, he was appointed as a Professor of Research in the Chemistry Department at Syracuse University, recognizing his contributions to rapid detection technologies and molecular science.
 
Key Innovations & Contributions:

Oral Insulin and Drug Delivery:

In 2012, he gained international attention by developing what may be the first clinically viable oral insulin formulation. His Serum-Specific Nano-encapsulation (SSNe) delivery system protects therapeutic agents through the digestive tract, enabling efficient absorption into the bloodstream. Reported bioavailability ranged between 73% and 98%, a significant improvement over conventional methods.

Biodegradable Building Materials:

He has also developed BioCrete, a formulation using marine polymers as an eco-friendly alternative to concrete, featured on the cover of Architecture Magazine in 2013.drdanieldebrouse
Biomimicry in Fermentation:

DeBrouse contributed to the biotech industry by pioneering “Biosymbiotic Fermentation,” where communities of microbes cooperatively produce, isolate, and purify bioactive substances—advancing biomimicry in industrial processes.

Virology and Antiviral Research:

In molecular virology, he conducted research on recombinant strategies against HIV-1, hepatitis C virus (HCV), recombinant vaccines, antivirals, and proposed novel in vivo models such as chimeric mice for HCV studies.
 
Professional Roles & Leadership:

He is the CEO and Chief Scientific Officer of Tamarisk Technologies, LLC, a company he founded in 2009 to further his multidisciplinary research across drug delivery, sustainable materials, automotive technologies, alternative energy, and biotech.
Some sources note that he is currently—or was recently—the Chief Scientific Officer of Advanced Molar, working on 100% biodegradable building materials.Plastics News
LinkedIn profiles indicate that he holds a Ph.D. in Molecular Biology from CSU and was the Founder & CEO of Tamarisk Technologies Group.LinkedIn
 
Summary Snapshot:

Field
Notable Contribution
Food microbiology
Rapid Listeria detection assays at MicroTech
Drug delivery
SSNe system enabling oral insulin with high bioavailability
Biomimicry & fermentation
Biosymbiotic Fermentation methods for biotech applications
Sustainable materials
BioCrete—marine polymer–based biodegradable alternative to concrete
Molecular virology
Research on HIV-1, HCV, vaccines, antivirals, and in vivo models
Leadership & innovation
CEO/CSO roles at Tamarisk Technologies, involvement with Advanced Molar